CVS Health Corporation $CVS Shares Sold by Alps Advisors Inc.

Alps Advisors Inc. cut its stake in CVS Health Corporation (NYSE:CVS) by 6.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 327,214 shares of the pharmacy operator’s stock after selling 21,159 shares during the quarter. Alps Advisors Inc.’s holdings in CVS Health were worth $24,669,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. SOA Wealth Advisors LLC. boosted its stake in CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 131 shares during the last quarter. Symmetry Partners LLC increased its holdings in CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after buying an additional 141 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares in the last quarter. HF Advisory Group LLC grew its holdings in shares of CVS Health by 2.9% during the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after purchasing an additional 145 shares during the last quarter. Finally, United Asset Strategies Inc. boosted its stake in CVS Health by 1.8% during the 3rd quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock worth $667,000 after purchasing an additional 154 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CVS has been the topic of several recent research reports. TD Cowen boosted their price target on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Mizuho boosted their target price on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Finally, Argus cut their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Stock Performance

NYSE CVS opened at $78.38 on Friday. The business has a 50 day moving average price of $78.62 and a 200 day moving average price of $75.65. The company has a market capitalization of $99.50 billion, a P/E ratio of 206.27, a PEG ratio of 0.72 and a beta of 0.50. CVS Health Corporation has a 1-year low of $53.36 and a 1-year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.